These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

130 related articles for article (PubMed ID: 10699331)

  • 21. Comparing the immunogenicity and safety of 3 Japanese encephalitis vaccines in Asia-Pacific area: A systematic review and meta-analysis.
    Wang SY; Cheng XH; Li JX; Li XY; Zhu FC; Liu P
    Hum Vaccin Immunother; 2015; 11(6):1418-25. PubMed ID: 25915588
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Sero-Molecular Epidemiology of Japanese Encephalitis in Zhejiang, an Eastern Province of China.
    Pan JR; Yan JY; Zhou JY; Tang XW; He HQ; Xie RH; Mao HY; Zhang YJ; Xie SY
    PLoS Negl Trop Dis; 2016 Aug; 10(8):e0004936. PubMed ID: 27560360
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Coverage & missed opportunity for Japanese encephalitis vaccine, Gorakhpur division, Uttar Pradesh, India, 2015: Implications for Japanese encephalitis control.
    Murhekar MV; Oak C; Ranjan P; Kanagasabai K; Shinde S; Pandey AK; Mittal M; Gore M; Mehendale SM
    Indian J Med Res; 2017 Jan; 145(1):63-69. PubMed ID: 28574016
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Japanese encephalitis vaccines: recommendations of the Advisory Committee on Immunization Practices (ACIP).
    Fischer M; Lindsey N; Staples JE; Hills S;
    MMWR Recomm Rep; 2010 Mar; 59(RR-1):1-27. PubMed ID: 20224546
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Effect of current Japanese encephalitis vaccine on different strains of Japanese encephalitis virus.
    Okuno Y; Okamoto Y; Yamada A; Baba K; Yabuuchi H
    Vaccine; 1987 Jun; 5(2):128-32. PubMed ID: 3037813
    [TBL] [Abstract][Full Text] [Related]  

  • 26. IXIARO updated: overview of clinical trials and developments with the inactivated vaccine against Japanese encephalitis.
    Jelinek T
    Expert Rev Vaccines; 2013 Aug; 12(8):859-69. PubMed ID: 23984958
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Safety and immunogenicity of a freeze-dried, Vero cell culture-derived, inactivated Japanese encephalitis vaccine (KD-287, ENCEVAC®) versus a mouse brain-derived inactivated Japanese encephalitis vaccine in children: a phase III, multicenter, double-blinded, randomized trial.
    Yun KW; Lee HJ; Kang JH; Eun BW; Kim YJ; Kim KH; Kim NH; Hong YJ; Kim DH; Kim HM; Cha SH
    BMC Infect Dis; 2015 Jan; 15():7. PubMed ID: 25567119
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Safety and immunogenicity of concomitant vaccination with the cell-culture based Japanese Encephalitis vaccine IC51 and the hepatitis A vaccine HAVRIX1440 in healthy subjects: A single-blind, randomized, controlled Phase 3 study.
    Kaltenböck A; Dubischar-Kastner K; Eder G; Jilg W; Klade C; Kollaritsch H; Paulke-Korinek M; von Sonnenburg F; Spruth M; Tauber E; Wiedermann U; Schuller E
    Vaccine; 2009 Jul; 27(33):4483-9. PubMed ID: 19486955
    [TBL] [Abstract][Full Text] [Related]  

  • 29. The efficacy of Japanese encephalitis vaccine in Henan, China: a case-control study.
    Luo D; Yin H; Xili L; Song J; Wang Z
    Southeast Asian J Trop Med Public Health; 1994 Dec; 25(4):643-6. PubMed ID: 7667706
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Australian Case-Control Study of Adverse Reactions to Japanese Encephalitis Vaccine.
    Robinson P; Ruff T; Kass R
    J Travel Med; 1995 Sep; 2(3):159-164. PubMed ID: 9815377
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Primary and booster immune responses to SA14-14-2 Japanese encephalitis vaccine in Korean infants.
    Sohn YM; Park MS; Rho HO; Chandler LJ; Shope RE; Tsai TF
    Vaccine; 1999 May; 17(18):2259-64. PubMed ID: 10403593
    [TBL] [Abstract][Full Text] [Related]  

  • 32. [A large-scale study on the safety and epidemiological efficacy of Japanese encephalitis (JE) live vaccine (SA14-14-2) in the JE endemic areas].
    Zhou B; Jia L; Xu X
    Zhonghua Liu Xing Bing Xue Za Zhi; 1999 Feb; 20(1):38-41. PubMed ID: 10682513
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Product review on the JE vaccine IXIARO.
    Firbas C; Jilma B
    Hum Vaccin Immunother; 2015; 11(2):411-20. PubMed ID: 25621812
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Allergy to IXIARO and BIKEN Japanese encephalitis vaccines.
    McCallum AD; Jones ME
    J Travel Med; 2013; 20(1):60-2. PubMed ID: 23279235
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Trial of inactivated Japanese encephalitis vaccine in children with underlying diseases.
    Yamada A; Imanishi J; Juang RF; Fukunaga T; Okuno Y; Tadano M; Fukai K; Baba K; Yabuuchi H
    Vaccine; 1986 Mar; 4(1):32-4. PubMed ID: 3008460
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Randomized, double-blind, placebo-controlled phase 3 trial of the safety and tolerability of IC51, an inactivated Japanese encephalitis vaccine.
    Tauber E; Kollaritsch H; von Sonnenburg F; Lademann M; Jilma B; Firbas C; Jelinek T; Beckett C; Knobloch J; McBride WJ; Schuller E; Kaltenböck A; Sun W; Lyons A
    J Infect Dis; 2008 Aug; 198(4):493-9. PubMed ID: 18588481
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Prevalence of anti-gelatin IgE antibodies in people with anaphylaxis after measles-mumps rubella vaccine in the United States.
    Pool V; Braun MM; Kelso JM; Mootrey G; Chen RT; Yunginger JW; Jacobson RM; Gargiullo PM;
    Pediatrics; 2002 Dec; 110(6):e71. PubMed ID: 12456938
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Smallpox vaccination and adverse reactions. Guidance for clinicians.
    Cono J; Casey CG; Bell DM;
    MMWR Recomm Rep; 2003 Feb; 52(RR-4):1-28. PubMed ID: 12617510
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Efficacy of single-dose SA 14-14-2 vaccine against Japanese encephalitis: a case control study.
    Bista MB; Banerjee MK; Shin SH; Tandan JB; Kim MH; Sohn YM; Ohrr HC; Tang JL; Halstead SB
    Lancet; 2001 Sep; 358(9284):791-5. PubMed ID: 11564484
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Immunogenicity of a Japanese encephalitis chimeric virus vaccine as a booster dose after primary vaccination with SA14-14-2 vaccine in Thai children.
    Janewongwirot P; Puthanakit T; Anugulruengkitt S; Jantarabenjakul W; Phasomsap C; Chumket S; Yoksan S; Pancharoen C
    Vaccine; 2016 Oct; 34(44):5279-5283. PubMed ID: 27628323
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.